Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.3100+0.1200 (+2.86%)
At close: 04:00PM EDT
4.0250 -0.28 (-6.61%)
After hours: 05:51PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference

    SOLANA BEACH, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that management will participate in the Gastroenterology and Hepatology Advanced Practice Providers Conference taking place from September 12 – 14, 2024 at the Gaylord National Resort Convention Center in National Harbor, Maryland. “As a

  • GlobeNewswire

    Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference

    SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that management will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place from September 9 – 11, 2024 at the Lotte New York Palace Hotel in New York City. Evoke’s presentation covering the recent positi

  • Simply Wall St.

    Evoke Pharma Second Quarter 2024 Earnings: Misses Expectations

    Evoke Pharma ( NASDAQ:EVOK ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.55m (up 125% from 2Q...